In order to scale, manage profitability and deliver an excellent patient experience, providers will need to leverage innovative technology.”

— Shane Reeves

June 20, 2024 / — TwelveStone Health Partners, a leading provider of comprehensive chronic care medication services, announced today that chief executive officer, Shane Reeves and chief operating officer, Cannon Loughry will be leading the keynote session at the 2024 Annual Conference of the National Infusion Center Association (NICA) to be held June 21 and June 22 in Las Vegas, Nevada.

The session entitled, “The Future of Infusion: AI, Technology, and Trends” will explore the convergence of infusion therapy, advancements in Artificial Intelligence (AI), and evolving market dynamics to uncover new opportunities and challenges. The panel, which will also include Ashley Joseph, senior vice president of client services, Infusion Centers at LeanTaaS, Inc. will discuss how AI-driven predictive analytics and related technologies are revolutionizing the infusion therapy industry, empowering healthcare providers and payers with real-time data and insights to promote seamless care coordination. They will consider how the regulatory landscape is shaping the adoption and use of these new technologies and address potential concerns about the limitations or risks associated with these innovations.

“I am honored to have this opportunity to share information with industry leaders around important topics like AI and the impact of technology in the infusions services market. In order to scale, manage profitability and deliver an excellent patient experience providers will need to leverage innovative technology,” said Shane Reeves, chief executive officer, TwelveStone Health Partners.

To schedule an interview or for more information on TwelveStone Health Partners, please contact Amanda Cecconi at
For more information about the 2024 NICA Annual Conference, please contact Alex Brown at

Click here to register for the 2024 NICA Annual Conference.

For more information about NICA, please visit